🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study relies on the hypotheses that (1) exhaled breath is intimately c...
Status
Completed
Location
Hôpital Necker - Enfants malades
Start Date
2023-02-06
Trial ID
NCT05726994
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and tolerability ...
Status
Not Yet Recruiting
Location
UOC Fibrosi Cistica - AOUI Verona
Start Date
2026-01-15
Trial ID
NCT07289035
Treatments Being Tested
Despite the increasingly common use of cystic fibrosis transmembrane conduc...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-08-25
Trial ID
NCT06350461
Treatments Being Tested
Observational study on women with Cystic Fibrosis treated with CFTR modulat...
Status
Recruiting
Location
Stockholm CF center
Start Date
2024-03-15
Trial ID
NCT06302270
Cystic fibrosis (CF) is characterized by various extrapulmonary manifestati...
Status
Unknown
Location
HCL - Hôpital Renée Sabran
Start Date
2024-02-19
Trial ID
NCT06251622
Treatments Being Tested
The purpose of this study is to validate and utilize a personalized medicin...
Status
Recruiting
Location
CCHMC
Start Date
2021-05-01
Trial ID
NCT04580368
Treatments Being Tested
This study aims to evaluate the pharmacokinetic changes during pregnancy, p...
Status
Not Yet Recruiting
Location
University of Minnesota
Start Date
2027-01-01
Trial ID
NCT04940533
The study aims to test whether use of CFTR modulators (ETI) improves fastin...
Status
Enrolling By Invitation
Location
University of Alabama at Birmingham
Start Date
2026-05-28
Trial ID
NCT07102043
The purpose of the study is to develop new biomarkers for studies of cystic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2010-03
Trial ID
NCT01348204
Treatments Being Tested
This is a 3-part, single-ascending dose Phase 1a randomized, double-blind, ...
Status
Recruiting
Location
Canberra Hospital
Start Date
2023-03-21
Trial ID
NCT05802264